Dako, Quintiles Partner on Personalized Rx; First Project to Focus on AstraZeneca Cancer Rx
November 03, 2010
Dako, Quintiles Partner on Personalized Rx; First Project to Focus on AstraZeneca Cancer Rx
Dako and Quintiles have joined forces to develop companion diagnostics and drugs and to work with pharma to bring personalized medicine products to market.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Quintiles' PGx Focus Continues with London Genetics Personalized Medicine Alliance
November 30, 2010 / Pharmacogenomics Reporter - Dako, Quintiles Ink Personalized Medicine Alliance
November 1, 2010 / GenomeWeb Daily News - AstraZeneca, Dako Team on Companion Dx
January 18, 2010 / GenomeWeb Daily News - KineMed, MedImmune Studying Role of Protein Dynamics in Neurodegenerative Diseases
May 21, 2013 / GenomeWeb Daily News - Oxford Cancer Biomarkers Developing CDx Biomarkers for AstraZeneca
April 16, 2013 / GenomeWeb Daily News